HDAC6 and Alzheimer disease: The putative therapeutic potential of HDAC6 inhibitors has been reported in different experimental models, both in vitro and in vivo; in these models, the use of slightly different HDAC6i has made it possible to obtain encouraging results, with the recovery of cognitive abilities in models of Alzheimer’s disease [10] and fragile X syndrome [11].